Are Purplebricks Group PLC, Babcock International Group PLC And Bodycote PLC Set To Beat The FTSE 100?

Are these 3 stocks worth buying right now? Purplebricks Group PLC (LON: PURP), Babcock International Group PLC (LON: BAB) and Bodycote PLC (LON: BOY).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The last year has been a rather disappointing one for investors in heat treatment services specialist Bodycote (LSE: BOY). That’s because its shares have fallen by 15%, which puts them 6% behind the performance of the FTSE 100. Looking ahead, there could be more underperformance ahead, with Bodycote’s valuation still indicating that it’s up with events despite its recent pullback.

For example, Bodycote trades on a price-to-earnings (P/E) ratio of 16.2 and yet is forecast to record a fall in earnings of 6% in the current year. Certainly, the company is expected to return to growth next year, but growth of 7% is roughly in line with that of the wider index and may not tempt investors to buy a slice of the business. In fact, Bodycote’s price-to-earnings-growth (PEG) ratio of 2.3 is rather high and doesn’t indicate that growth is on offer at a reasonable price.

In addition, Bodycote’s yield of 2.6% is also far less than the FTSE 100’s yield of just under 4%. As such, there seem to be better options available elsewhere.

Growth potential

Unlike Bodycote, estate agency Purplebricks (LSE: PURP) has soared in value in recent months, with its shares rising by 62% since the turn of the year.

Clearly, Purplebricks is a relatively young business and it has the potential to grow at a rapid rate. Moreover, it’s proving to be somewhat disruptive within the estate agency space, with Purplebricks having a different pricing model than most traditional estate agencies and this has so far been somewhat popular among house sellers. And with it expected to move from loss to profit over the next year, it would be unsurprising for Purplebricks’ share price to move higher in the coming weeks and months.

However, from an investment perspective it’s difficult to overcome Purplebricks’ high valuation. It trades on a forward P/E ratio of 47 and even though it has potential to become a highly profitable business in the long run, it may be wise to await a keener valuation before buying it.

Margin of safety

Meanwhile, engineering support services company Babcock (LSE: BAB) has outperformed the FTSE 100 by 5% in the last year and this could be set to continue. That’s because it offers good growth prospects at a fair price and while it’s due to change its CEO later in the year, it seems to have a wide margin of safety at the present time.

For example, Babcock is forecast to grow its earnings by 9% in each of the next two years and yet has a P/E ratio of just 12. This equates to a PEG ratio of only 1.3, which indicates that its shares offer significant upside potential. Allied to this is a yield of 2.9% and with dividends being covered 2.9 times by profit, there seems to be tremendous scope for a rapidly rising dividend. With demand for income stocks set to remain high, Babcock could see investor sentiment improve and therefore its shares look set to continue beating the wider index.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has recommended Bodycote. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

This FTSE AIM travel business could absolutely skyrocket in 2025

FTSE AIM stock Jet2 appears to be a bargain in plain sight. I’m desperately searching for reasons not to buy…

Read more »

Investing Articles

This Bank of England news makes me fear for Lloyds and its share price!

Warnings of weak economic growth, resurgent inflation, and falling interest rates pose a toxic cocktail for Lloyds' share price.

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

2 UK shares that could soar if interest rates sprint lower!

The Bank of England's latest meeting has fed speculation of swingeing interest rate cuts. I think these UK shares could…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

My favourite FTSE dividend stock just jumped 17%! So why am I sad?

This investor has mixed feelings today as a quality dividend stock from the FTSE 250 surged higher in his portfolio.…

Read more »

Investing Articles

Here’s why AstraZeneca stock jumped nearly 6% in the FTSE 100 today

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were cheering.

Read more »

Closeup of "interest rates" text in a newspaper
Investing Articles

Interest rates fall again! Here are 3 FTSE dividend growth shares to consider buying

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for passive…

Read more »

Investing Articles

Up 10% today, I think this FTSE 250 growth share could continue to surge!

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be getting started.

Read more »

Investing Articles

The AstraZeneca share price jumps 5% on today’s strong results – but is it too expensive?

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's biggest company…

Read more »